News
March 2023
Congratulations to Seongmin, Nawon, and Minchae for their publication in BMB Rep. (Impact Factor: 5.041).
CD4+ cytotoxic T cells: an emerging effector arm of anti-tumor immunity. BMB Rep. 2023; 56(2):140-144.
December 2022
A perspective article from our lab and Zhang's lab at Harvard Medical School has been published in Trends Immunol. (Impact Factor: 19.709).
Does Delayed EBV Infection contribute to Rising Childhood Cancers? Trends Immunol. 2022; 43(12):956-958.
October 2022
A new paper has been published in Clin Cancer Res. (Impact Factor: 13.801).
Facts and hopes in the relationship of EBV with cancer immunity and immunotherapy. Clin Cancer Res. 2022; 28(20):4363-4369.
September 2022
The Choi lab was awarded a prestigious and highly selective grant ("중견연구") from the National Research Foundation of Korea.